Pure Pharm Peptides

Pure Pharm Peptides

Research Supplier

Age Verification Required

This website sells research-grade compounds intended for laboratory use only.

You must be 21 years of age or older to access this site.

For Research Use Only

Not for Human Consumption

By entering, you confirm you are 21+ and agree to our Terms of Service.

Anti-Aging ResearchMarch 3, 20268 min read

GHK-Cu and Collagen Synthesis: What the Research Shows

Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.

Introduction

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma albumin by Pickart and Thaler in 1973. It is found in plasma, saliva, and urine, with plasma concentrations declining significantly with age — from approximately 200 ng/mL in young adults to near-undetectable levels in individuals over 60 [1]. This age-related decline has made GHK-Cu a subject of considerable interest in aging biology, wound healing, and skin research.

GHK-Cu's biological activity is mediated through its ability to bind copper(II) ions with high affinity, forming a stable complex that interacts with a wide range of cellular receptors and signaling pathways. The peptide has been studied in over 50 years of published research, making it one of the most comprehensively characterized copper-binding peptides in the scientific literature.

Molecular Characteristics

| Parameter | Value | |---|---| | Full name | Glycyl-L-histidyl-L-lysine copper(II) complex | | Molecular formula | C₁₄H₂₄N₆O₄ (peptide); C₁₄H₂₄CuN₆O₄ (copper complex) | | Molecular weight | ~340 Da (peptide); ~403 Da (copper complex) | | CAS number | 89030-95-5 (copper complex) | | Endogenous source | Human plasma, saliva, urine | | Copper binding | High-affinity Cu(II) chelation |

Mechanism of Action: Collagen Synthesis

Fibroblast Activation

GHK-Cu's most well-characterized effect is stimulation of collagen synthesis in fibroblasts. In vitro studies demonstrate that GHK-Cu increases the production of collagen types I, III, and IV, as well as elastin and proteoglycans — the structural proteins that provide skin and connective tissue with tensile strength and elasticity [2]. The mechanism involves upregulation of TGF-β1 (transforming growth factor beta-1) signaling in fibroblasts, which drives collagen gene expression through the Smad2/3 transcription pathway.

Notably, GHK-Cu simultaneously stimulates the production of matrix metalloproteinases (MMPs) — enzymes that degrade damaged or disorganized collagen — creating a coordinated remodeling response rather than simple collagen accumulation. This dual action (synthesis + remodeling) produces more organized, functional collagen architecture compared to interventions that only stimulate synthesis [3].

Copper-Dependent Enzyme Activation

The copper component of GHK-Cu plays a critical role in activating lysyl oxidase, a copper-dependent enzyme essential for cross-linking collagen and elastin fibers. Cross-linking is the process that converts newly synthesized collagen monomers into the stable, mechanically strong fibrillar structures found in mature connective tissue. Without adequate copper-mediated cross-linking, collagen synthesis alone does not produce functional tissue architecture [4].

Wound Healing Research

GHK-Cu has been extensively studied in wound healing models. Key findings from preclinical research include:

Angiogenesis stimulation: GHK-Cu promotes formation of new blood vessels in wound beds through upregulation of VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor) expression, improving oxygen and nutrient delivery to healing tissue [5].

Macrophage recruitment: The peptide acts as a chemoattractant for macrophages and mast cells, accelerating the inflammatory phase of wound healing and improving debris clearance from wound sites.

Keratinocyte migration: In skin wound models, GHK-Cu enhances keratinocyte migration across wound surfaces, accelerating re-epithelialization — the process by which new skin forms over a wound.

Tensile strength: Animal wound healing studies demonstrate that GHK-Cu-treated wounds achieve greater tensile strength at earlier time points compared to untreated controls, consistent with improved collagen organization [6].

Anti-Inflammatory Properties

GHK-Cu exhibits significant anti-inflammatory activity in experimental models. Research demonstrates downregulation of NF-κB signaling — a master regulator of inflammatory gene expression — and reduction of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 in cell culture and animal models. This anti-inflammatory profile complements its pro-healing effects, as excessive inflammation can impair wound healing and accelerate tissue degradation [7].

Skin Biology and Aging Research

In skin aging research, GHK-Cu has been studied for its effects on:

- Dermal collagen density: Topical and systemic GHK-Cu application increases dermal collagen content in aged skin models - Skin thickness: Studies in aged rodents demonstrate increased dermal thickness following GHK-Cu treatment - Antioxidant gene expression: GHK-Cu upregulates expression of antioxidant enzymes including superoxide dismutase (SOD) and catalase through activation of the Nrf2/ARE pathway - DNA repair: Research suggests GHK-Cu may enhance DNA repair mechanisms in UV-damaged skin cells through upregulation of repair enzymes [8]

A 2025 systematic review in PMC confirmed that tripeptides including GHK-Cu demonstrate significant potential in wound healing and skin regeneration research models, with consistent findings across multiple independent research groups [9].

Research Applications

GHK-Cu is utilized as a research tool in studies examining: - Wound healing mechanisms and tissue repair biology - Skin aging and dermal collagen remodeling - Anti-inflammatory signaling pathways - Angiogenesis and vascular biology - Copper-dependent enzyme activity and metalloprotein biology


For research use only. Not for human or animal consumption.

References

  1. Pickart, L., & Thaler, M.M. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology, 243(124), 85–87.
  2. Maquart, F.X., et al. (1993). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 238(2), 343–346.
  3. Pickart, L., et al. (2015). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015, 648108.
  4. Rucker, R.B., et al. (1998). Copper, lysyl oxidase, and extracellular matrix protein cross-linking. American Journal of Clinical Nutrition, 67(5 Suppl), 996S–1002S.
  5. Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987.
  6. Leyden, J.J., & Rawlings, A.V. (2002). Skin moisturization. Cosmetic Science and Technology Series, 25, 1–544.
  7. Gorouhi, F., & Maibach, H.I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345.
  8. Pickart, L. (2008). The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 19(8), 969–988.
  9. Adnan, S.B., et al. (2025). Tripeptides in wound healing and skin regeneration. PMC, 12595317.

Research Grade Available

Pure Pharm Peptides offers research-grade GHK-Cu with ≥99% HPLC purity, independently verified by third-party laboratories.